TipRanks
Go Ultimate55% OFF

HLS Therapeutics Inc (74D) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

74D Analyst Ratings

Moderate Buy
2Ratings
1Buy1Hold0Sell
Based on 2 analysts giving stock ratings to HLS Therapeutics Inc in the past 3 months

74D Stock 12 Month Forecast

EUR 5.23▲(102.80% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for HLS Therapeutics Inc in the last 3 months. The average price target is EUR 5.23 with a high forecast of EUR 7.63 and a low forecast of EUR 2.83. The average price target represents a 102.80% change from the last price of EUR 2.58.
Highest Price TargetEUR 7.63Average Price TargetEUR 5.23Lowest Price TargetEUR 2.83

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:74D
Price TargetFollowArticle
Stifel NicolausEUR 2.83hold9.72%UpsideReiterated08/14/26
Bloom BurtonEUR 7.63buy195.87%UpsideReiterated08/13/26
Canaccord GenuityEUR 3.18hold23.28%UpsideInitiated05/19/26
Raymond JamesEUR 3.82→EUR 4.45buy72.59%UpsideReiterated11/18/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRVITrevi Therapeutics
RZLTRezolute
CELCCelcuity
AXGNAxoGen
HROWHarrow Health

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering HLS Therapeutics Inc

3 Months
David Martin PhD
David Martin PhDBloom Burton
Success Rate18/39 ratings generated profit
46%
Average Return
+8.06%

Copying David Martin PhD's trades and holding each position for 3 Months would result in 46.15% of your transactions generating a profit, with an average return of +8.06% per trade.

1 Year
David Martin PhD
David Martin PhDBloom Burton
Success Rate17/39 ratings generated profit
44%
Average Return
+9.09%

Copying David Martin PhD's trades and holding each position for 1 Year would result in 43.59% of your transactions generating a profit, with an average return of +9.09% per trade.

2 Years
David Martin PhD
David Martin PhDBloom Burton
Success Rate15/39 ratings generated profit
38%
Average Return
+1.83%

Copying David Martin PhD's trades and holding each position for 2 Years would result in 38.46% of your transactions generating a profit, with an average return of +1.83% per trade.

74D Analyst Recommendation Trends

02468Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for 74D
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy11110
Buy00000
Hold11110
Sell00000
Strong Sell00000
total22220

In the current month, 74D has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 74D average Analyst price target in the past 3 months is 5.23.

74D Financial Forecast

EUR -2EUR -1.5EUR -1EUR -0.5EUR 0Q3 2025Q2 2026Q3 2026
HighEUR -0.04
ConsensusEUR -0.06
LowEUR -0.08

74D Earnings Forecast

Next quarter’s earnings estimate for 74D is -EUR 0.06 with a range of -EUR 0.08 to -EUR 0.04. The previous quarter’s EPS was -EUR 0.03. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

EUR 11.2MEUR 11.8MEUR 12.4MEUR 12.9MEUR 13.5MQ3 2025Q2 2026Q3 2026
HighEUR 13.4M
ConsensusEUR 13.3M
LowEUR 13M

74D Sales Forecast

Next quarter’s sales forecast for 74D is EUR 13.27M with a range of EUR 13.02M to EUR 13.38M. The previous quarter’s sales results were EUR 12.92M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

74D Stock Forecast FAQ

What is DE:74D’s average 12-month price target, according to analysts?
Based on analyst ratings, HLS Therapeutics Inc’s 12-month average price target is €5.23.
What is DE:74D’s upside potential, based on the analysts’ average price target?
HLS Therapeutics Inc has 102.80% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is HLS Therapeutics Inc a Buy, Sell or Hold?
HLS Therapeutics Inc has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
What is HLS Therapeutics Inc’s share price target?
The average share price target for HLS Therapeutics Inc is €5.23. This is based on 2 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €7.63, and the lowest forecast is €2.83. The average share price target represents a 102.80% increase from the current price of €2.58.
What do analysts say about HLS Therapeutics Inc?
HLS Therapeutics Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of HLS Therapeutics Inc?
To buy shares of DE:74D, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.